{
"NDC": {
"NDCCode": "17201-013-30",
"PackageDescription": "1 BOTTLE in 1 CARTON (17201-013-30) / 30 CAPSULE in 1 BOTTLE",
"NDC11Code": "17201-0013-30",
"ProductNDC": "17201-013",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Omcazio",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Cabozantinib Laurylsulfate",
"DosageFormName": "CAPSULE",
"RouteName": "ORAL",
"StartMarketingDate": "20261101",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA220613",
"LabelerName": "Handa Pharma",
"SubstanceName": "CABOZANTINIB LAURYLSULFATE",
"StrengthNumber": "34.5",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-11-03",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20261101",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}